SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-16-000628
Filing Date
2016-08-05
Accepted
2016-08-05 09:23:27
Documents
7
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER DATED AUGUST 5, 2016 auriniapharma6kq2.htm 6-K 6679
2 INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SECOND QUARTER ENDED exhibit99-1.htm EX-99.1 253675
3 MD&A FOR THE SECOND QUARTER ENDED JUNE 30, 2016 exhibit99-2.htm EX-99.2 229575
4 CERTIFICATION OF INTERIM FILINGS - CHIEF EXECUTIVE OFFICER exhibit99-3.htm EX-99.3 9660
5 CERTIFICATION OF INTERIM FILINGS - CHIEF FINANCIAL OFFICER exhibit99-4.htm EX-99.4 11406
6 exhibit99-2x17x1.jpg GRAPHIC 2208
7 exhibit99-3x1x1.jpg GRAPHIC 3970
  Complete submission text file 0001176256-16-000628.txt   520764
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 161809273
SIC: 2834 Pharmaceutical Preparations